Please login to the form below

Not currently logged in
Email:
Password:

EASD 2013

This page shows the latest EASD 2013 news and features for those working in and with pharma, biotech and healthcare.

Novo backs Victoza's prospects in Alzheimer's

Novo backs Victoza's prospects in Alzheimer's

Speaking to PMLiVE at the European Association for the Study of Diabetes' (EASD) 2013 meeting in Barcelona last week, Novo's chief science officer Mads Krogsgaard Thomsen confirmed the drug, approved ... the end of 2013.

Latest news

More from news
Approximately 4 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics